Ammar Ahmed, Elewa Ahmed, Emam Amr Y, Sharief Mohamed, Kamel Omnia
Cardiology Department, Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom.
Cardiology Department, Ain Shams University, Cairo, Egypt.
Front Cardiovasc Med. 2024 Dec 5;11:1495689. doi: 10.3389/fcvm.2024.1495689. eCollection 2024.
Biventricular pacing (BiVP) has been the cornerstone of cardiac resynchronization therapy (CRT) in the management of symptomatic heart failure patients with reduced ejection fraction (HFrEF) and electrical dyssynchrony despite guideline-directed medical therapy (GDMT). However, BiVP has some limitations, including technical difficulties and high non-response rates. Conduction system pacing encompassing His bundle pacing (HBP) and left bundle branch area pacing (LBBAP) has recently emerged as a promising alternative to CRT in this group of patients. In this review, we explore the current evidence, guidelines, limitations, gaps in knowledge, and ongoing trials comparing CSP and BiVP for the management of HFrEF with electrical dyssynchrony.
双心室起搏(BiVP)一直是心脏再同步治疗(CRT)的基石,用于治疗尽管接受了指南指导的药物治疗(GDMT)但仍有症状的射血分数降低(HFrEF)和电不同步的心力衰竭患者。然而,BiVP存在一些局限性,包括技术困难和高无反应率。包括希氏束起搏(HBP)和左束支区域起搏(LBBAP)在内的传导系统起搏最近已成为这组患者中CRT的一种有前景的替代方法。在本综述中,我们探讨了目前关于比较传导系统起搏(CSP)和BiVP治疗伴有电不同步的HFrEF的证据、指南、局限性、知识空白以及正在进行的试验。